CT screening for lung cancer: Are we ready to implement in Europe?

Haval Balata; Matthew Evison; Anna Sharman; Philip Crosbie; Richard Booton

doi:10.1016/j.lungcan.2019.05.028

CT screening for lung cancer: Are we ready to implement in Europe?

Haval Balata^*, Matthew Evison, Anna Sharman, Philip Crosbie, Richard Booton

^*Corresponding author for this work

Manchester Academic Health Science Centre (MAHSC)

Research output: Contribution to journal › Review article › peer-review

Abstract

Lung cancer screening with low-dose CT (LDCT) is already available in certain parts of the world, such as the United States, but not yet in Europe. The recently published European position statement on lung cancer screening has recommended planning for implementation of screening to start within 18-months [1]. Pilot European programmes are already underway, primarily in the United Kingdom (UK), delivering lung cancer screening to their local populations. This review article acknowledges the evidence base for LDCT screening and will discuss the challenges that still need to be overcome in an attempt to answer the question: are we ready to implement in Europe?

Original language	English
Pages (from-to)	25-33
Number of pages	9
Journal	Lung Cancer
Volume	134
Early online date	28 May 2019
DOIs	https://doi.org/10.1016/j.lungcan.2019.05.028
Publication status	Published - 1 Aug 2019

Keywords

Early detection
Low-dose CT (LDCT)
Lung cancer
Lung cancer screening

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.lungcan.2019.05.028

Cite this

@article{6d316b3489404c8b9436af91f0cfdfd0,

title = "CT screening for lung cancer: Are we ready to implement in Europe?",

abstract = "Lung cancer screening with low-dose CT (LDCT) is already available in certain parts of the world, such as the United States, but not yet in Europe. The recently published European position statement on lung cancer screening has recommended planning for implementation of screening to start within 18-months [1]. Pilot European programmes are already underway, primarily in the United Kingdom (UK), delivering lung cancer screening to their local populations. This review article acknowledges the evidence base for LDCT screening and will discuss the challenges that still need to be overcome in an attempt to answer the question: are we ready to implement in Europe?",

keywords = "Early detection, Low-dose CT (LDCT), Lung cancer, Lung cancer screening",

author = "Haval Balata and Matthew Evison and Anna Sharman and Philip Crosbie and Richard Booton",

year = "2019",

month = aug,

day = "1",

doi = "10.1016/j.lungcan.2019.05.028",

language = "English",

volume = "134",

pages = "25--33",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - CT screening for lung cancer

T2 - Are we ready to implement in Europe?

AU - Balata, Haval

AU - Evison, Matthew

AU - Sharman, Anna

AU - Crosbie, Philip

AU - Booton, Richard

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Lung cancer screening with low-dose CT (LDCT) is already available in certain parts of the world, such as the United States, but not yet in Europe. The recently published European position statement on lung cancer screening has recommended planning for implementation of screening to start within 18-months [1]. Pilot European programmes are already underway, primarily in the United Kingdom (UK), delivering lung cancer screening to their local populations. This review article acknowledges the evidence base for LDCT screening and will discuss the challenges that still need to be overcome in an attempt to answer the question: are we ready to implement in Europe?

AB - Lung cancer screening with low-dose CT (LDCT) is already available in certain parts of the world, such as the United States, but not yet in Europe. The recently published European position statement on lung cancer screening has recommended planning for implementation of screening to start within 18-months [1]. Pilot European programmes are already underway, primarily in the United Kingdom (UK), delivering lung cancer screening to their local populations. This review article acknowledges the evidence base for LDCT screening and will discuss the challenges that still need to be overcome in an attempt to answer the question: are we ready to implement in Europe?

KW - Early detection

KW - Low-dose CT (LDCT)

KW - Lung cancer

KW - Lung cancer screening

U2 - 10.1016/j.lungcan.2019.05.028

DO - 10.1016/j.lungcan.2019.05.028

M3 - Review article

AN - SCOPUS:85066406853

SN - 0169-5002

VL - 134

SP - 25

EP - 33

JO - Lung Cancer

JF - Lung Cancer

ER -

CT screening for lung cancer: Are we ready to implement in Europe?

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this